Seres Therapeutics (MCRB) Secures $3.6M in CARB-X Funding for Breakthrough SER-155 Program
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a pioneer in the field of live biotherapeutic products, emerging from the earliest…
Nuvation Bio (NUVB) Receives $10 Analyst Target After 204-Patient Trial Milestone
Nuvation Bio Inc. (NYSE:NUVB) is a specialized biopharmaceutical company founded with the mission of developing transformative therapies for…
Medtronic (MDT) Reports $9 Billion Revenue Surge
Medtronic plc (NYSE:MDT) is one of the world’s largest, oldest, and most influential medical technology companies, with a…
Boston Scientific (BSX) Set for a 25% Rally? Analysts Predict $127.55 Price Target
Boston Scientific Corporation (NYSE:BSX) is one of the world’s leading medical technology companies, built on a history of…
Kazia Therapeutics (KZIA) Faces NASDAQ Delisting After Missing Compliance Deadline — Is This the End?
Kazia Therapeutics Limited (NASDAQ:KZIA) is an Australia-based biotechnology company dedicated to the development of innovative, targeted oncology therapies…
Olema Pharma (OLMA) Surges After Roche’s Phase 3 Win Validates Oral SERDs
Olema Pharmaceuticals Inc. (NASDAQ:OLMA) is a clinical-stage biotechnology company founded with a singular mission: to transform the treatment…
Is Fulcrum Therapeutics (FULC) the Next Rare-Disease Winner? New Data Says YES
Fulcrum Therapeutics Inc. (NASDAQ:FULC) has built its identity as a clinical-stage biopharmaceutical company committed to transforming the lives…
Avalo Therapeutics (AVTX) Set for 167.86% Surge? Piper Sandler Reaffirms Massive $48 Price Target
Avalo Therapeutics Inc. (NASDAQ:AVTX) is a clinical-stage biotechnology company built on a focused mission to develop innovative therapies…
Black Diamond Therapeutics (BDTX) Surges 115.9% YTD
Black Diamond Therapeutics (NASDAQ:BDTX) is a precision-oncology biotechnology company built on the idea that cancers driven by genetically…
Rhythm Pharma (RYTM) Surges as FDA Extends Review for IMCIVREE
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is a biopharmaceutical company founded with a singular scientific focus: developing transformative therapies for…
Nuvalent (NUVL) Soars 16% After ALKOVE-1 Trial Shows 86% Response in TKI-Naïve Lung Cancer Patients
Nuvalent, Inc. (NASDAQ:NUVL) is a clinical-stage biotechnology company founded on the vision of designing precisely targeted therapies for…
Cypherpunk Technologies (CYPH) Skyrockets 284% in One Week After $58.9M Crypto Pivot
Cypherpunk Technologies (NASDAQ:CYPH) is a newly transformed digital-asset company that emerged from the rebranding of Leap Therapeutics, marking…
Cytek Bio (CTKB) Surges 39% in 1 Month After TIME 2026 Recognition
Cytek Biosciences Inc. (NASDAQ:CTKB) is a leading life-sciences technology company specializing in advanced cell analysis, driven by its…
Why Indaptus (INDP) Could Be a Sleeper Biotech Winner After $2.3M Financing Boost and Phase 1 Progress
Indaptus Therapeutics Inc. (NASDAQ:INDP) is a clinical-stage biotechnology company built around a bold scientific premise: that the next…
Is Apimeds (APUS) the Most Undervalued Small-Cap Biotech?
Apimeds Pharmaceuticals US Inc. (NYSE:APUS) is a clinical-stage biopharmaceutical company built on a mission to transform pain management…
DiaMedica (DMAC) Advances Preeclampsia Trial as Cash Runway Extends to 2027
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for serious diseases driven…
YD Bio (YDES) Surges After $13.2M Financing
YD Bio Limited (NASDAQ:YDES) is a biotechnology company built on a dual scientific foundation: advancing DNA methylation–based cancer…
Why Analysts Believe Oscar Health (OSCR) Could Become a $12B-Plus Digital Insurance Powerhouse
Oscar Health Inc. (NASDAQ:OSCR) is a technology-driven health insurance company founded with the mission of making healthcare simple,…